High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects

European Respiratory Journal

Volumn 23, Issue 6, 2004, Pages 916-920

  Sartori, C ^a   Duplain, H ^a   Lepori, M ^a   Egli, M ^a   Maggiorini, M ^b   Nicod, P ^a   Scherrer, Urs ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alveolar fluid clearance; High altitude; Hypoxia; Pulmonary oedema; Transepithelial sodium transport

Indexed keywords

AMILORIDE;

ADULT; ALTITUDE DISEASE; ARTICLE; CELL MEMBRANE POTENTIAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; IN VIVO STUDY; LUNG EDEMA; MALE; MOUNTAINEERING; NOSE MUCOSA; PRIORITY JOURNAL; SODIUM TRANSPORT;

EID: 3042547049     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00115304     Document Type: Article

References (35)

1. Maggiorini M, Melot C, Pierre S, et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001; 103: 2078-2083.
2. Scherrer U, Sartori C, Lepori M, et al. High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport. Adv Exp Med Biol 1999; 474: 93-107.
3. Scherrer U, Vollenweider L, Delabays A, et al. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 1996; 334: 624-629.
4. Sartori C, Allemann Y, Trueb L, et al. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr 2000; 130: 385-389.
5. Sartori C, Matthay MA, Scherrer U. Transepithelial sodium and water transport in the lung. Major player and novel therapeutic target in pulmonary edema. Adv Exp Med Biol 2001; 502: 315-338.
6. Matthay MA, Flori HR, Conner ER, Ware LB. Alveolar epithelial fluid transport: basic mechanisms and clinical relevance. Proc Assoc Am Physician 1998; 110: 496-505.
7. Sartori C, Matthay MA. Alveolar epithelial fluid transport in acute lung injury: new insights. Eur Respir J 2002; 20: 1299-1313.
8. Matalon S, O'Brodovich H. Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Ann Rev Physiol 1999; 61: 627-661.
9. Egli M, Sartori C, Duplain H, et al. Impaired alveolar fluid clearance and augmented susceptibility to lung edema in mice with defective amiloride sensitive sodium transport. FASEB J 2000; 14: A127.
10. 2-subunits of Na-K-ATPase in the lung decreases maximal epithelial fluid clearance and increases susceptibility to pulmonary edema in mice. Am J Respir Crit Care Med 2002; 165: A413.
11. Knowles MR, Carson JL, Collier AM, Gatzy JT, Boucher RC. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 1981; 124: 484-490.
12. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346: 1631-1636.
13. Frank JA, Wang Y, Osorio O, Matthay MA. Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 2000; 89: 1255-1265.
14. Planès C, Escoubet B, Blot-Chabaud M, Friedlander G, Farman N, Clerici C. Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar type II cells. Am J Resp Cell Mol Biol 1997; 17: 508-518.
15. Clerici C, Matthay MA. Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 2000; 88: 1890-1896.
16. Sakuma T, Okaniwa G, Nakada T, Nishimura T, Fujimura S, Matthay MA. Alveolar fluid clearance in the resected human lung. Am J Respir Crit Care Med 1994; 150: 305-310.
17. Vivona ML, Matthay M, Chabaud MB, Friedlander G, Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am J Respir Cell Mol Biol 2001; 25: 554-561.
18. Knowles MR, Buntin W, Bromberg PA, Gatzy JT, Boucher RC. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am Rev Respir Dis 1982; 126: 108-112.
19. Vock P, Fretz C, Franciolli M, Bärtsch P. High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology 1989; 170: 661-666.
20. Knowles MR, Hohneker KW, Zhou Z, et al. Controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995; 333: 823-831.
21. Gowen CW Jr, Lawson EE, Gingras J, Boucher RC, Gatzy JT, Knowles MR. Electrical potential difference and ion transport across nasal epithelium of term neonates: correlation with mode of delivery, transient tachypnea of the newborn, and respiratory rate. J Pediatr 1988; 113: 121-127.
22. Sauder RA, Chesrown SE, Loughlin GM. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J Pediatr 1987; 111: 353-358.
23. Boucher RC. Molecular insights into physiology of the "thin film" of airway surface liquid. J Physiol 1999; 516: 631-638.
24. Baker E, Jeunemaitre X, Portal AJ, et al. Abnormalities of nasal potential difference measurement in Liddle's syndrome. J Clin Invest 1998; 102: 10-14.
25. Olivier R, Scherrer U, Horisberger JD, Rossier BC, Hummler E. Selected contribution: limiting Na(+) transport rate in airway epithelia from alpha-ENaC transgenic mice: a model for pulmonary edema. J Appl Physiol 2002; 93: 1881-1887.
26. Tomlinson LA, Carpenter TC, Baker EH, Bridges JB, Weil JV. Hypoxia reduces airway epithelial sodium transport in rats. Am J Physiol 1999; 277: L881-L886.
27. Suzuki S, Noda M, Sugita M, Ono S, Koike K, Fujimura S. Impairment of transalveolar fluid transport and lung Na(+)-K(+)-ATPase function by hypoxia in rats. J Appl Physiol 1999; 87: 962-968.
28. Planes C, Friedlander G, Loiseau A, Amiel C, Clerici C. Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line. Am J Physiol 1996; 271: L70-L78.
29. De Angelis C, Farrace S, Urbani L, et al. Effects of high-altitude exposure on plasma and urinary digoxin-like immunoreactive substance. Am J Hypertens 1992; 5: 600-607.
30. Heberlein W, Wodopia R, Bartsch P, Mairbaurl H. Possible role of ROS as mediators of hypoxia-induced ion transport inhibition of alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 278: L640-L648.
31. Snyder PM. Liddle's syndrome mutations disrupt cAMP-mediated translocation of the epithelial Na(+) channel to the cell surface. J Clin Invest 2000; 105: 45-53.
32. Plane's C, Blot-Chabaud M, Matthay MA, Couette S, Uchida T, Clerici C. Hypoxia and beta2-agonists regulate cell surface expression of epithelial sodium channel in native alveolar epithelial cells. J Biol Chem 2002; 277: 47318-47324.
33. Sakuma T, Suzuki S, Usuda K, et al. Preservation of alveolar epithelial fluid transport mechanisms in rewarmed human lung after severe hypothermia. J Appl Physiol 1996; 80: 1681-1686.
34. Mason NP, Petersen M, Melot C, et al. Serial changes in nasal potential difference and lung electrical impedance tomography at high altitude. J Appl Physiol 2003; 94: 2043-2050.
35. Mairbaurl H, Weymann J, Mohrlein A, et al. Nasal epithelium potential difference at high altitude (4,559 m): evidence for secretion. Am J Respir Crit Care Med 2003; 167: 862-867.